XML 49 R38.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stock-based Compensation - Additional Information (Detail)
$ in Millions
6 Months Ended
Apr. 10, 2015
shares
Oct. 30, 2013
shares
Jun. 30, 2016
USD ($)
plan
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Options outstanding, weighted average remaining contractual life In years)     7 years 9 months
Number of equity compensation plans | plan     2
Additional awards granted     758,736
2013 Omnibus incentive plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Additional awards granted 0    
Equity awards (up to)     5,729,068
2005 Aerie Pharmaceutical stock plan and 2013 omnibus incentive plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unrecognized compensation expense | $     $ 29.8
Compensation cost, weighted average recognition period (in years)     2 years 6 months
Options outstanding, weighted average remaining contractual life In years)     7 years 9 months
2005 Aerie Pharmaceutical Stock Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Additional awards granted   0  
Restricted stock      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unrecognized compensation expense | $     $ 2.9
Restricted stock awards, weighted average remaining contractual term (in years)     3 years
Restricted stock | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based awards, vesting period In years)     1 year
Restricted stock | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based awards, vesting period In years)     4 years